Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • REVIEWS
  • MENUS
  • RESOURCES
    • Side effect handouts
    • Patient handouts: Main page
    • How to find treatment resources
    • Rating scales and questionnaires for mental health clinicians
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • LOG IN
  • JOIN

Aripiprazole with sensor (Abilify Mycite®): Basic Information

Aripiprazole with sensor (US brand name Abilify Mycite®) is a drug-device combination consisting of aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor for tracking drug ingestion. Here is basic information about this medication.

FDA-approved indications

1. Treatment of adults with schizophrenia

2. Treatment of bipolar I disorder

  • Acute treatment of adults with manic and mixed episodes as monotherapy and as adjunct to lithium or valproate
  • Maintenance treatment of adults as monotherapy and as adjunct to lithium or valproate

3. Adjunctive treatment of adults with major depressive disorder (MDD)


Dosage

Schizophrenia – adults

Initial Dose: 10-15 mg/day

Recommended Dose: 10-15 mg/day

Maximum Dose: 30 mg/day

Bipolar mania – adults: monotherapy

Initial Dose: 15 mg/day

Recommended Dose: 15 mg/day

Maximum Dose: 30 mg/day

Bipolar mania – adults: adjunct to lithium or valproate

Initial Dose: 10-15 mg/day

Recommended Dose: 15 mg/day

Maximum Dose: 30 mg/day

Major Depressive Disorder – Adults adjunct to antidepressants

Initial Dose: 2-5 mg/day

Recommended dose: 5-10 mg/day M

Maximum dose: 15 mg/day


Instructions

Administer once daily without regard to meals

Swallow whole; do not divide, crush, or chew

Known CYP2D6 poor metabolizers: Administer half of the usual dose


Limitations of use

1. It is not established that aripiprazole with sensor can improve patient compliance or modify aripiprazole dosage

2. Aripiprazole with sensor is not recommended for tracking drug ingestion in real-time or during an emergency because detection may be delayed or not occur


Dosage forms and strengths (USA)

Tablets with sensor: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg

Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.


Related Pages

 FDA issues new warning about aripiprazole (impulse control problems)

Be careful in converting from Abilify Maintena® to Aristada®

Aripiprazole (Abilify Maintena®)

Aripiprazole lauroxil (Aristada®)


References

Prescribing information for aripiprazole with sensor (Abilify Mycite®)


Copyright 2017, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.

Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.

Share this:

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email

Leave a Reply:Cancel reply

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter

Copyright 2016 to 2025: Simple and Practical Medical Education, LLC. All rights reserved.